These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 1559217

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
    Achkar CC, Bentel JM, Boylan JF, Scher HI, Gudas LJ, Miller WH.
    Drug Metab Dispos; 1994; 22(3):451-8. PubMed ID: 8070324
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.
    Lefebvre P, Thomas G, Gourmel B, Agadir A, Castaigne S, Dreux C, Degos L, Chomienne C.
    Leukemia; 1991 Dec; 5(12):1054-8. PubMed ID: 1774953
    [Abstract] [Full Text] [Related]

  • 4. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
    Tzimas G, Nau H, Hendrickx AG, Peterson PE, Hummler H.
    Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
    [Abstract] [Full Text] [Related]

  • 5. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
    Zhou DC, Hallam SJ, Lee SJ, Klein RS, Wiernik PH, Tallman MS, Gallagher RE.
    Cancer Res; 1998 Dec 15; 58(24):5770-6. PubMed ID: 9865735
    [Abstract] [Full Text] [Related]

  • 6. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Dec 15; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 7. Elevated plasma lipid peroxide content correlates with rapid plasma clearance of all-trans-retinoic acid in patients with advanced cancer.
    Muindi JF, Scher HI, Rigas JR, Warrell RP, Young CW.
    Cancer Res; 1994 Apr 15; 54(8):2125-8. PubMed ID: 8174117
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Biological parameters of the efficiency of retinoic acid in acute leukemia].
    Chomienne C, Cornic M, Castaigne S, Lefebvre P, de Thé H, Dejean A, Degos L.
    C R Seances Soc Biol Fil; 1991 Apr 15; 185(6):456-63. PubMed ID: 1822394
    [Abstract] [Full Text] [Related]

  • 10. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat.
    Tzimas G, Thiel R, Chahoud I, Nau H.
    Toxicol Appl Pharmacol; 1997 Apr 15; 143(2):436-44. PubMed ID: 9144460
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasma pharmacokinetics and metabolism of 13-cis- and all-trans-retinoic acid in the cynomolgus monkey and the identification of 13-cis- and all-trans-retinoyl-beta-glucuronides. A comparison to one human case study with isotretinoin.
    Kraft JC, Slikker W, Bailey JR, Roberts LG, Fischer B, Wittfoht W, Nau H.
    Drug Metab Dispos; 1991 Apr 15; 19(2):317-24. PubMed ID: 1676630
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia.
    Miller WH, Jakubowski A, Tong WP, Miller VA, Rigas JR, Benedetti F, Gill GM, Truglia JA, Ulm E, Shirley M.
    Blood; 1995 Jun 01; 85(11):3021-7. PubMed ID: 7756637
    [Abstract] [Full Text] [Related]

  • 16. Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia.
    Lanvers C, Reinhardt D, Dübbers A, Wagner-Bohn A, Creutzig U, Ritter J, Boos J.
    Med Pediatr Oncol; 2003 May 01; 40(5):293-301. PubMed ID: 12652617
    [Abstract] [Full Text] [Related]

  • 17. 4-Oxoretinol, a metabolite of retinol in the human promyelocytic leukemia cell line NB4, induces cell growth arrest and granulocytic differentiation.
    Faria TN, Rivi R, Derguini F, Pandolfi PP, Gudas LJ.
    Cancer Res; 1998 May 01; 58(9):2007-13. PubMed ID: 9581846
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 20. Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits.
    Eckhoff C, Chari S, Kromka M, Staudner H, Juhasz L, Rudiger H, Agnish N.
    Toxicol Appl Pharmacol; 1994 Mar 01; 125(1):34-41. PubMed ID: 8128493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.